More tools:Markets·Screener·Research·Chat

Lisata Therapeutics, Inc. Common Stock (LSTA) Financial Statements

Lisata Therapeutics, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SBTRW6
XNAS · usd
1.86▲ 0.21 (12.73%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close1.65
Day's Range1.62 – 1.89
52-Week Range0.99 – 5.08
Volume250.0K
Avg Volume393.8K
Share Statistics
Shares Outstanding
Employees21
ExchangeXNAS
Listed1999-03-01
Share count as of August 6, 2026
Loading Income Statement…
Key questions about Lisata Therapeutics, Inc. Common Stock (LSTA)
What is Lisata Therapeutics, Inc. Common Stock's Market Cap?
Lisata Therapeutics, Inc. Common Stock's Market Cap is $16.8M, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's Enterprise Value?
Lisata Therapeutics, Inc. Common Stock's Enterprise Value is $6.3M, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's Price / Sales?
Lisata Therapeutics, Inc. Common Stock's Price / Sales is 167.6×, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's EV / Revenue?
Lisata Therapeutics, Inc. Common Stock's EV / Revenue is 63.2×, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's EV / EBITDA?
Lisata Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's Revenue (TTM)?
Lisata Therapeutics, Inc. Common Stock's Revenue (TTM) is $100.0K, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's Net Income (TTM)?
Lisata Therapeutics, Inc. Common Stock's Net Income (TTM) is -$14.6M, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's EBITDA?
Lisata Therapeutics, Inc. Common Stock's EBITDA is -$16.4M, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?
Lisata Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.62, based on as-reported figures from SEC (XBRL) filings.
What is Lisata Therapeutics, Inc. Common Stock's EBITDA Margin?
Lisata Therapeutics, Inc. Common Stock's EBITDA Margin is -16362.0%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue—
YoY growth-100.0%—-90.0%—
Operating Expenses:
Research and development
General and administrative
Total operating expenses—
% of revenue————
Operating loss
% of revenue——-3079.0%—
Other income (expense):
Investment income, net
Other income (expense), net
Total other income
Net loss before benefit from income taxes and noncontrolling interests
Net loss
% of revenue——-2954.0%—
Less - net income (loss) attributable to noncontrolling interests
Net loss attributable to Lisata Therapeutics, Inc. common stockholders
% of revenue——-2954.0%—
Lisata Therapeutics, Inc. common stockholders- basic (in dollars per share)
Lisata Therapeutics, Inc. common stockholders - diluted (in dollars per share)